Roseburia intestinalis

   RANK: Species

TAXONOMY: Terrabacteria group -> Firmicutes -> Clostridia -> Clostridiales -> Lachnospiraceae -> Roseburia -> Roseburia intestinalis

OVERVIEW:

Roseburia intestinalis is a saccharolytic, butyrate-producing bacterium first isolated from human feces. It is anaerobic, gram-positive, slightly curved rod-shaped and motile by means of multiple subterminal flagella. Roseburia favors and loves starches that escape small intestinal degradation and RS3, cooked-cooled starches. R. intestinalis works synergistically often with Bifidobacteria. Very low carbohydrate diets can cause Roseburia counts to drop, which can cause butyrate to drop as well. Chitin and beta-glucan encourage Roseburia. (as does low dose RS2, green banana flour or RPS). High dose RS2 however will decrease Roseburia (Tachon /2013). Lower concentrations in Type II diabetics.

This species has been identified as a resident in the human gastrointestinal tract based on the phylogenetic framework of its small subunit ribosomal RNA gene sequences.[PMC 4262072]

1

COGEM
COGEM released a comprehensive database of pathogenicity assessment of around 2575 bacterial species in 2011. The database ranks the pathogenicity of species on a scale of 1 to 4. Roseburia intestinalis ranks 1 on this scale: The species or strain does not belong to a recognized group of disease-invoking agents in humans or animals and/or has an extended history of safe usage under conditions without any physical restrictions
Identified as a 'core species' of the human gut microbiome. [PMID: 23222524]

TAGS
Keystone Core species Type species Pathogen Dysbiosis associated Flora/ commensal Gut associated Probiotic
Leanness Obesity Skin microbiome Fecal distribution Oral microbiome Vaginal microbiome Butyrate producer Catalase producer
Histamine producer Food fermenter Amylolytic Propionate producer Nitrifying Biofilm producer
INTERACTIONS
KEGG PATHWAYS

CLUSTERS WITH
METABOLOMICS       
NUTRIENTS/ SUBSTRATES
  • Resistant starch (type II) [parent]
  • N-Acetyl-D-glucosamine [parent]
  • β-Glucan
  • Resistant starch (type III)
  • Acetate [parent]
  • Resistant starch (type II)
  • β-Glucan [parent]
  • Chitin
  • N-Acetyl-D-glucosamine
  • Resistant starch (type III) [parent]
  • Arabinoxylans [parent]
  • Raffinose [parent]
  • Stachyose (soy oligosaccharide) [parent]
  • Chitin [parent]

  • ENDPRODUCTS
  • Lactate [parent]
  • Butyrate [parent]
  • Butyrate

  • INHIBITED BY
  • High animal protein diet [parent]
  • Low carbohydrate diet [parent]
  • Ketogenic diet [parent]
  • High meat diet [parent]
  • Epinephrine [parent]
  • Fructo-oligosaccharides [parent]

  • ENHANCED BY
  • Resistant starch (type II) [parent]
  • Almonds/ almond skins [parent]
  • Polymannuronic acid [parent]
  • Vitamin D [parent]
  • N-Acetyl-D-glucosamine [parent]
  • Dopamine [parent]
  • β-Glucan [parent]
  • Walnuts [parent]
  • Arabinoxylans [parent]
  • Dietary fiber [parent]

  • BIOTRANSFORMS

    BIOTRANFORM
    ANTIBIOTIC RESISTANCE   BIOFILM FORMERS   COGEM PATHOGENICITY   

    OPUS 23™ IS A REGISTERED TRADEMARK ® OF DATAPUNK BIOINFORMATICS, LLC. COPYRIGHT © 2015-2023. ALL RIGHTS RESERVED.     |